News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,656 Results
Type
Article (1126)
Company Profile (3)
Press Release (37527)
Section
Business (14087)
Career Advice (13)
Deals (2932)
Drug Delivery (2)
Drug Development (3194)
Employer Resources (3)
FDA (562)
Job Trends (640)
News (18440)
Policy (1520)
Tag
2027 Pharm Country Standard (1)
Academia (61)
Accelerated approval (2)
Allergies (1)
Alliances (2632)
ALS (9)
Alzheimer's disease (113)
Antibody-drug conjugate (ADC) (14)
Approvals (587)
Artificial intelligence (50)
ASCO (9)
Autoimmune disease (14)
Automation (1)
Bankruptcy (21)
Belgium (10)
Best Places to Work (376)
BIO (6)
Biologics (1)
Biosimilars (4)
BioSpace Insights (1)
Biotechnology (16)
Bispecific (1)
Bladder cancer (9)
Brain cancer (4)
Breast cancer (77)
Cancer (298)
Cardiovascular disease (10)
Career advice (13)
CAR-T (1)
CDC (1)
Cell therapy (26)
Clinical research (2723)
Collaboration (111)
Commercialization (1)
Compensation (11)
Complete response letters (1)
COVID-19 (229)
CRISPR (1)
C-suite (80)
Cystic fibrosis (3)
Data (289)
Depression (8)
Dermatology (1)
Diabetes (11)
Diagnostics (457)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (4616)
Employer resources (3)
ESMO (14)
Events (5032)
Executive appointments (74)
FDA (700)
Fragile X (3)
Funding (111)
Gene editing (3)
Generative AI (1)
Gene therapy (3)
GLP-1 (25)
Government (121)
Guidances (13)
Healthcare (1004)
Hematology (1)
HIV (1)
Huntington's disease (3)
IgA nephropathy (2)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (3)
Infectious disease (241)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (9)
Interviews (3)
IPO (1164)
Job creations (272)
Job search strategy (10)
Kidney disease (4)
Layoffs (11)
Legal (607)
Liver cancer (1)
Longevity (2)
Lung cancer (22)
Lymphoma (3)
Machine learning (5)
Management (1)
Manufacturing (41)
Medical device (763)
Medtech (775)
Mergers & acquisitions (1889)
Metabolic disorders (17)
mRNA (5)
Multiple sclerosis (4)
Neurodegenerative disease (15)
Neuropsychiatric disorders (2)
Neuroscience (165)
NextGen: Class of 2026 (270)
Non-profit (93)
Obesity (5)
Opinion (3)
Ovarian cancer (3)
Pain (14)
Pancreatic cancer (25)
Parkinson's disease (9)
Partnered (12)
Patents (30)
Patient recruitment (24)
Patient selection (4)
People (4332)
Pharmaceutical (4)
Phase 1 (832)
Phase 2 (1370)
Phase 3 (808)
Pipeline (368)
Postmarket research (65)
Preclinical (366)
Press Release (2)
Prostate cancer (21)
Psychedelics (3)
Radiopharmaceuticals (29)
Rare diseases (46)
Real estate (281)
Recruiting (1)
Regulatory (990)
Reports (23)
Research institute (72)
Rett syndrome (5)
RNA editing (3)
RSV (1)
Schizophrenia (5)
Series A (8)
Series B (4)
Service/supplier (2)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (198)
State (1)
Supply chain (3)
Vaccines (34)
Venture capital (1)
Weight loss (2)
Women's health (3)
Date
Today (10)
Last 7 days (30)
Last 30 days (127)
Last 365 days (1577)
2026 (1264)
2025 (1652)
2024 (1919)
2023 (2178)
2022 (2944)
2021 (3668)
2020 (2875)
2019 (1938)
2018 (1513)
2017 (1418)
2016 (1383)
2015 (1703)
2014 (1425)
2013 (1179)
2012 (1325)
2011 (1316)
2010 (1430)
Location
Africa (39)
Alabama (2)
Arizona (14)
Asia (1426)
Australia (133)
California (388)
Canada (1275)
China (10)
Colorado (18)
Connecticut (7)
Delaware (12)
Europe (2787)
Florida (102)
Georgia (10)
Idaho (3)
Illinois (43)
India (6)
Indiana (55)
Japan (30)
Kansas (3)
Kentucky (2)
Louisiana (3)
Maryland (31)
Massachusetts (250)
Michigan (56)
Minnesota (79)
Montana (9)
Nebraska (3)
Nevada (10)
New Hampshire (11)
New Jersey (288)
New Mexico (7)
New York (232)
North Carolina (82)
North Dakota (1)
Northern California (193)
Ohio (20)
Oklahoma (4)
Oregon (1)
Pennsylvania (216)
Puerto Rico (1)
South America (52)
South Carolina (1)
Southern California (121)
Tennessee (10)
Texas (224)
United States (2196)
Utah (6)
Virginia (10)
Washington D.C. (1)
Washington State (22)
Wisconsin (45)
Wyoming (3)
38,656 Results for "dyax corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
COSCIENS ACQUIRES NUALTIS CORP.
September 10, 2026
·
19 min read
Press Releases
Vector Science & Therapeutics Corp. Appoints Russell Starr as President
October 14, 2026
·
4 min read
Press Releases
OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026
October 14, 2026
·
1 min read
Press Releases
Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board
October 26, 2026
·
2 min read
Press Releases
Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering
October 15, 2026
·
2 min read
Press Releases
Protect Pharmaceutical Corp. Announces Closing of Environmental Infrastructure Acquisitions
August 18, 2026
·
5 min read
Press Releases
NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference
September 27, 2026
·
3 min read
Press Releases
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
·
3 min read
Press Releases
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
September 23, 2026
·
3 min read
Press Releases
Dragonfleye Therapeutics Corp. Takes Flight, Raising US$37.5 Million in Private Placement Offerings to Advance Novel Ocular Platform-Based Treatments
October 26, 2026
·
3 min read
1 of 3,866
Next
